James Nelson's most recent trade in Co-Diagnostics Inc was a trade of 48,334 Restricted Stock Unit done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 48,334 | 103,333 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 48,334 | 211,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 163,333 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 151,667 | - | - | Restricted Stock Unit | |
| Chewy Inc - Ordinary Share... | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2024 | 8,133 | 8,133 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 30,000 | 115,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 30,000 | 200,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 110,000 | 230,000 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | James L. Nelson | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.22 per share. | 18 Sep 2023 | 1,286 | 69,993 (0%) | 0% | 11.2 | 14,429 | Common Stock |
| Chewy Inc - Ordinary Share... | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 4,880 | 4,880 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 70,000 | 150,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 18,333 | 80,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 18,333 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,576 | 30,576 | - | - | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 24,899 | 37,677 (0%) | 0% | - | Common Stock | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 24,899 | 0 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | James L. Nelson | CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.09 per share. | 03 May 2023 | 1,597 | 71,279 (0%) | 0% | 11.1 | 17,711 | Common Stock |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 40,000 | 98,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 58,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 36,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 70,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 24,167 (0%) | 0% | 0 | Common Stock | |
| Chewy Inc - Ordinary Share... | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 5,145 | 5,145 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 70,000 | 82,500 | - | - | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 24,899 | 37,677 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 12,778 | 24,899 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 12,778 | 12,778 (0%) | 0% | 0 | Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.87 per share. | 10 May 2022 | 13,745 | 74,283 (0%) | 0% | 12.9 | 176,898 | Common Stock |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 35,100 | 88,028 (0%) | 0% | 0 | Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.78 per share. | 03 May 2022 | 1,597 | 52,928 (0%) | 0% | 13.8 | 22,007 | Common Stock |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 149 | 12,778 | - | 0 | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Chewy Inc - Ordinary Share... | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 1,607 | 1,607 (0%) | 0% | 0 | Class A Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 26,225 | 54,525 (0%) | 0% | 0 | Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | 18 Jun 2021 | 2,135,496 | 2,135,496 (2%) | 2% | - | Common Stock | ||
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | 18 Jun 2021 | 2,135,496 | 0 | - | - | OP Units | ||
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 18 Jun 2021 | 106,774 | 28,300 (0%) | 0% | 18.5 | 1,972,116 | Common Stock |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | 14 Jun 2021 | 2,135,496 | 0 | - | - | LTIP Units | ||
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | 14 Jun 2021 | 2,135,496 | 2,135,496 | - | - | OP Units | ||
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 419,434 | 2,135,496 | - | - | LTIP Units | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 2,500,000 | 2,500,000 | - | - | LTIP Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 12,629 | 12,629 | - | 0 | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 13 Jan 2021 | 11,900 | 600 (0%) | 0% | 10.1 | 120,547 | Common Stock |
| Co-Diagnostics Inc | James Nelson | Director | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 13 Jan 2021 | 600 | 0 (0%) | 0% | 10.1 | 6,084 | Common Stock |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 14,300 | 28,300 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | James L. Nelson | Director | Sale of securities on an exchange or to another person at price $ 49.81 per share. | 01 Sep 2020 | 7,000 | 18,959 (0%) | 0% | 49.8 | 348,670 | Common Stock |
| W & T Offshore Inc | S. James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 27,344 | 191,688 (0%) | 0% | 0 | COMMON STOCK |